Enliven Therapeutics, Inc. SEC filings ELVN

Enliven Therapeutics, Inc. has 798 filings in SEC EDGAR's recent list, going back to Apr 21, 2016. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Enliven Therapeutics, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 3, 2026 Oct 30, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 27, 2026 —
4 Insider transaction Oct 21, 2026 Oct 19, 2026
4 Insider transaction Oct 21, 2026 Oct 19, 2026
144 Notice of proposed sale Oct 19, 2026 —
4 Insider transaction Oct 16, 2026 Oct 14, 2026
3 Initial insider ownership Oct 16, 2026 Oct 14, 2026
4 Insider transaction Oct 5, 2026 Oct 1, 2026
144 Notice of proposed sale Oct 1, 2026 —
4 Insider transaction Sep 21, 2026 Sep 17, 2026
4 Insider transaction Sep 21, 2026 Sep 17, 2026
144 Notice of proposed sale Sep 17, 2026 —
144 Notice of proposed sale Sep 4, 2026 —
4 Insider transaction Aug 19, 2026 Aug 17, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
4 Insider transaction Aug 6, 2026 Aug 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 6, 2026 —
144 Notice of proposed sale Aug 4, 2026 —
4 Insider transaction Jul 21, 2026 Jul 17, 2026
4 Insider transaction Jul 21, 2026 Jul 17, 2026
144 Notice of proposed sale Jul 17, 2026 —
4 Insider transaction Jul 8, 2026 Jul 6, 2026
4 Insider transaction Jun 24, 2026 Jun 22, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 24, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
144 Notice of proposed sale Jun 22, 2026 —
4 Insider transaction Jun 22, 2026 Jun 17, 2026
4 Insider transaction Jun 22, 2026 Jun 17, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Jun 22, 2026 —
4 Insider transaction Jun 17, 2026 Jun 15, 2026
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 17, 2026 —
144 Notice of proposed sale Jun 17, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
4 Insider transaction Jun 9, 2026 Jun 5, 2026
144 Notice of proposed sale Jun 5, 2026 —
4 Insider transaction May 20, 2026 May 18, 2026
144 Notice of proposed sale May 18, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
144 Notice of proposed sale Apr 30, 2026 —
4 Insider transaction Apr 21, 2026 Apr 17, 2026
144 Notice of proposed sale Mar 31, 2026 —
144 Notice of proposed sale Mar 31, 2026 —
4 Insider transaction Mar 27, 2026 Mar 25, 2026
144 Notice of proposed sale Mar 25, 2026 —
144 Notice of proposed sale Mar 24, 2026 —
4 Insider transaction Mar 19, 2026 Mar 17, 2026
4 Insider transaction Mar 11, 2026 Mar 9, 2026
4 Insider transaction Mar 10, 2026 Mar 6, 2026
144 Notice of proposed sale Mar 9, 2026 —
144 Notice of proposed sale Mar 6, 2026 —
4 Insider transaction Feb 19, 2026 Feb 17, 2026
4 Insider transaction Feb 19, 2026 Feb 17, 2026
144 Notice of proposed sale Feb 18, 2026 —
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
4 Insider transaction Feb 17, 2026 Feb 12, 2026
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
144 Notice of proposed sale Feb 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
4 Insider transaction Feb 10, 2026 Feb 6, 2026
144 Notice of proposed sale Feb 2, 2026 —
4 Insider transaction Jan 22, 2026 Jan 20, 2026
4 Insider transaction Jan 22, 2026 Jan 20, 2026
144 Notice of proposed sale Jan 20, 2026 —
4 Insider transaction Jan 13, 2026 Jan 9, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 12, 2026 Jan 8, 2026
4 Insider transaction Jan 9, 2026 Jan 7, 2026
3 Initial insider ownership Jan 9, 2026 Jan 7, 2026
144 Notice of proposed sale Jan 9, 2026 —
144 Notice of proposed sale Jan 9, 2026 —
144 Notice of proposed sale Jan 9, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Dec 23, 2025 Dec 22, 2025
4 Insider transaction Dec 23, 2025 Dec 19, 2025
4 Insider transaction Dec 19, 2025 Dec 17, 2025
144 Notice of proposed sale Dec 19, 2025 —
144 Notice of proposed sale Dec 17, 2025 —
4 Insider transaction Dec 12, 2025 Dec 11, 2025
3 Initial insider ownership Dec 12, 2025 Dec 11, 2025
4 Insider transaction Dec 10, 2025 Dec 8, 2025
144 Notice of proposed sale Dec 8, 2025 —
4 Insider transaction Nov 21, 2025 Nov 19, 2025
4 Insider transaction Nov 19, 2025 Nov 17, 2025
144 Notice of proposed sale Nov 19, 2025 —
144 Notice of proposed sale Nov 17, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
4 Insider transaction Nov 12, 2025 Nov 7, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 5, 2025 —
4 Insider transaction Oct 22, 2025 Oct 20, 2025
4 Insider transaction Oct 21, 2025 Oct 17, 2025
144 Notice of proposed sale Oct 20, 2025 —
144 Notice of proposed sale Oct 17, 2025 —
4 Insider transaction Oct 9, 2025 Oct 7, 2025
4 Insider transaction Oct 1, 2025 Sep 29, 2025
4 Insider transaction Sep 30, 2025 Sep 26, 2025
4 Insider transaction Sep 30, 2025 Sep 26, 2025
144 Notice of proposed sale Sep 29, 2025 —
4 Insider transaction Sep 25, 2025 Sep 23, 2025
4 Insider transaction Sep 25, 2025 Sep 23, 2025
4 Insider transaction Sep 23, 2025 Sep 19, 2025
4 Insider transaction Sep 19, 2025 Sep 17, 2025
144 Notice of proposed sale Sep 19, 2025 —
144 Notice of proposed sale Sep 17, 2025 —
4 Insider transaction Sep 10, 2025 Sep 8, 2025
144 Notice of proposed sale Sep 8, 2025 —
4 Insider transaction Aug 29, 2025 Aug 27, 2025
144 Notice of proposed sale Aug 27, 2025 —
4/A Filing Aug 21, 2025 Aug 18, 2025
4 Insider transaction Aug 21, 2025 Aug 19, 2025
4 Insider transaction Aug 20, 2025 Aug 18, 2025
144 Notice of proposed sale Aug 19, 2025 —
144 Notice of proposed sale Aug 18, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 11, 2025 Aug 7, 2025
144 Notice of proposed sale Aug 7, 2025 —
4 Insider transaction Jul 30, 2025 Jul 28, 2025
144 Notice of proposed sale Jul 28, 2025 —
4 Insider transaction Jul 23, 2025 Jul 21, 2025
4 Insider transaction Jul 21, 2025 Jul 17, 2025
144 Notice of proposed sale Jul 21, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jul 17, 2025 —
144 Notice of proposed sale Jul 17, 2025 —
4 Insider transaction Jul 14, 2025 Jul 10, 2025
4 Insider transaction Jul 9, 2025 Jul 7, 2025
144 Notice of proposed sale Jul 7, 2025 —
4 Insider transaction Jul 1, 2025 Jun 27, 2025
144 Notice of proposed sale Jun 27, 2025 —
4 Insider transaction Jun 24, 2025 Jun 20, 2025
144 Notice of proposed sale Jun 20, 2025 —
4 Insider transaction Jun 18, 2025 Jun 17, 2025
SCHEDULE 13D/A Amended ownership over 5% (active) Jun 17, 2025 —
4 Insider transaction Jun 17, 2025 Jun 13, 2025
144 Notice of proposed sale Jun 17, 2025 —
144 Notice of proposed sale Jun 13, 2025 —
4 Insider transaction Jun 11, 2025 Jun 9, 2025
144 Notice of proposed sale Jun 9, 2025 —
4 Insider transaction Jun 5, 2025 Jun 3, 2025
4 Insider transaction Jun 5, 2025 Jun 3, 2025
144 Notice of proposed sale Jun 3, 2025 —
144 Notice of proposed sale Jun 3, 2025 —
4 Insider transaction May 29, 2025 May 27, 2025
144 Notice of proposed sale May 27, 2025 —
4 Insider transaction May 21, 2025 May 19, 2025
4 Insider transaction May 21, 2025 May 19, 2025
144 Notice of proposed sale May 19, 2025 —
144 Notice of proposed sale May 19, 2025 —
4 Insider transaction May 9, 2025 May 7, 2025
144 Notice of proposed sale May 7, 2025 —
4 Insider transaction May 5, 2025 May 1, 2025
4 Insider transaction May 5, 2025 May 1, 2025
144 Notice of proposed sale May 1, 2025 —
144 Notice of proposed sale May 1, 2025 —
4 Insider transaction Apr 30, 2025 Apr 28, 2025
144 Notice of proposed sale Apr 28, 2025 —
4 Insider transaction Apr 23, 2025 Apr 21, 2025
4 Insider transaction Apr 21, 2025 Apr 17, 2025
144 Notice of proposed sale Apr 21, 2025 —
144 Notice of proposed sale Apr 17, 2025 —
144 Notice of proposed sale Apr 14, 2025 —
144 Notice of proposed sale Apr 14, 2025 —
4 Insider transaction Apr 9, 2025 Apr 7, 2025
144 Notice of proposed sale Apr 7, 2025 —
4 Insider transaction Mar 31, 2025 Mar 27, 2025
144 Notice of proposed sale Mar 27, 2025 —
4 Insider transaction Mar 26, 2025 Mar 24, 2025
4 Insider transaction Mar 21, 2025 Mar 19, 2025
4 Insider transaction Mar 19, 2025 Mar 17, 2025
144 Notice of proposed sale Mar 19, 2025 —
144/A Filing Mar 18, 2025 —
144/A Filing Mar 18, 2025 —
144 Notice of proposed sale Mar 18, 2025 —
144 Notice of proposed sale Mar 18, 2025 —
144 Notice of proposed sale Mar 17, 2025 —
144 Notice of proposed sale Mar 17, 2025 —
144 Notice of proposed sale Mar 17, 2025 —
4 Insider transaction Mar 11, 2025 Mar 7, 2025
144 Notice of proposed sale Mar 7, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ELVN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Burlingame, CA
SEC filer status
Non-accelerated filer
SEC CIK
1672619
Former names
IMARA Inc. (until Feb 23, 2023)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.